Mrinal Kammili

Dr. Kammili possesses more than 22 years of combined industry experience, in Hospital and Clinical Research domains in the Health Care Industry. Dr. Kammili is ICH-GCP certified, well versed in Indian and International Regulatory guidelines applicable to Bioequivalence and Bioavailability studies, Phase 1, Phase II-IV Trials, Medical Writing, Data Management, Pharmacovigilance and Medical Imaging.

Presently, Dr. Kammili is a member on the Board of Directors and Global Head–Business Development for International (US / EU / Turkey / S.E. Asia / ROW and Emerging) markets and Indian domestic market.

He is actively involved in all M&A activities of Lambda group of companies and as a successful P&L executive, has built and managed teams to deliver stretched goals with high profitability by creating improved systems, processes and synergies within the organizations to build efficiencies, credibility and trust among the stakeholders.

Apart from the Clinical Research Domain, Dr. Kammili is also a trained Intensivist, having assisted in various Interventional Cardiac emergency procedures like Primary Angioplasties, Coronary Angiograms, and Thrombolytic therapies.

He is also a certified Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) provider by the American Heart Association.